Drug level in human liver cytosol treated with capmatinib assessed as AOX-mediated metabolite formation at 10 uM after 30 min by UPLC/Q-TOF MS analysi...

Basic Information

ID: ALA4050244

Type: ADME

Description: Drug level in human liver cytosol treated with capmatinib assessed as AOX-mediated metabolite formation at 10 uM after 30 min by UPLC/Q-TOF MS analysis

Format: BAO_0000019

Organism: Homo sapiens

Tissue: Liver

Subcellular Fraction: Cytosol

Target:  Aldehyde oxidase(ALA3257)

Document:  ALA4049400

Drug level in human liver cytosol treated with capmatinib assessed as AOX-mediated metabolite formation at 10 uM after 30 min by UPLC/Q-TOF MS analysis: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
428.432.722.72